Ji Oh Mok
Overview
Explore the profile of Ji Oh Mok including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chun A, Jo H, Lee S, Chun H, Park J, Kim K, et al.
Endocrinol Metab (Seoul)
. 2014 Oct;
30(1):71-7.
PMID: 25325277
Background: Thyroid incidentalomas detected by 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) have been reported in 1% to 4% of the population, with a risk of malignancy of 27.8% to...
12.
Kim B, Chun A, Kim K, Jung C, Kang S, Mok J, et al.
Endocrinol Metab (Seoul)
. 2014 Oct;
29(4):457-63.
PMID: 25325264
Background: The aim of this study was to examine the clinical characteristics of adrenal incidentalomas discovered by computed tomography (CT) and to investigate metabolic features of subclinical Cushing's syndrome (SCS)...
13.
Choi S, Lim S, Hong E, Seo J, Park C, Noh J, et al.
Clin Endocrinol (Oxf)
. 2014 Aug;
82(5):670-7.
PMID: 25109606
Objective: Dyslipidaemia and central obesity are the major factors underlying the dramatic increase in metabolic syndrome (MS). We compared the effects of early combined therapy with pitavastatin and intensive lifestyle...
14.
Kim T, Lee D, Kim Y, Mok J, Kim C, Park J, et al.
Int J Geriatr Psychiatry
. 2014 Jul;
30(6):551-7.
PMID: 25060738
Objective: Insulin resistance (IR) is a distinct and early feature of type 2 diabetes mellitus and metabolic syndrome. IR is thought to play a vital role in cognitive impairment. We...
15.
Son J, Kim D, Lee C, Oh S, Song K, Jung C, et al.
J Diabetes Investig
. 2014 May;
4(5):466-74.
PMID: 24843697
Aims/introduction: Recently, patient-tailored statin therapy was proven effective for achieving target low-density lipoprotein (LDL) cholesterol levels. It is unclear, however, whether this therapeutic modality would be effective for atherogenic lipid...
16.
Kim K, Min Y, Koh J, Chung Y, Kim K, Byun D, et al.
Yonsei Med J
. 2014 Apr;
55(3):715-24.
PMID: 24719139
Vitamin D (vit-D) is essential for bone health, although many osteoporosis patients have low levels of 25-hydroxy-vit-D [25(OH)D]. This randomized, open-label study compared the effects of once weekly alendronate 70...
17.
Kim J, Park C, Ahn K, Cho J, Choi K, Kang J, et al.
Atherosclerosis
. 2014 Mar;
234(1):146-51.
PMID: 24657383
Objective: We evaluated the prevalence of aspirin resistance and predictive factors for aspirin resistance in Korean type 2 diabetes patients. Approach And Results: A total of 1045 type 2 diabetes...
18.
Choi Y, Shin H, Mok J
Aesthet Surg J
. 2013 Dec;
34(1):168-74.
PMID: 24334502
Background: Many surgeons are reluctant to perform fat grafting in patients with diabetes because soft-tissue healing is impaired, but no previous study has reported data-driven outcomes of fat grafting in...
19.
Mok J, Jung C, Kim C, Ryu C, Kim Y, Kim S, et al.
Korean J Intern Med
. 2013 Dec;
28(6):694-700.
PMID: 24307845
Background/aims: This study was performed to compare the mucosal findings after esophagogastroduodenoscopy in two groups before and after the use of alendronate only and following administration of the enteric-coated alendronate...
20.
Ko H, Kim B, Jung C, Chun S, Mok J, Kim Y, et al.
Korean J Intern Med
. 2012 Dec;
27(4):407-10.
PMID: 23269881
Background/aims: The relationship between Runt-related transcription factor 3 (RUNX3) gene inactivation and various solid tumors has been reported; however, little information is available about RUNX3 in thyroid cancers. Methods: We...